Milo Gatti, P. Cojutti, M. Bartoletti, T. Tonetti, Amedeo Bianchini, S. Ramirez, G. Pizzilli, S. Ambretti, M. Giannella, R. Mancini, A. Siniscalchi, P. Viale, F. Pea
{"title":"专家的临床药理学建议可能会使针对新出现的候选药物的抗菌TDM计划在临床上更适用于危重患者的定制治疗","authors":"Milo Gatti, P. Cojutti, M. Bartoletti, T. Tonetti, Amedeo Bianchini, S. Ramirez, G. Pizzilli, S. Ambretti, M. Giannella, R. Mancini, A. Siniscalchi, P. Viale, F. Pea","doi":"10.1186/s13054-022-04050-9","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":92888,"journal":{"name":"Critical care (Houten, Netherlands)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-06-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"35","resultStr":"{\"title\":\"Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients\",\"authors\":\"Milo Gatti, P. Cojutti, M. Bartoletti, T. Tonetti, Amedeo Bianchini, S. Ramirez, G. Pizzilli, S. Ambretti, M. Giannella, R. Mancini, A. Siniscalchi, P. Viale, F. Pea\",\"doi\":\"10.1186/s13054-022-04050-9\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":92888,\"journal\":{\"name\":\"Critical care (Houten, Netherlands)\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-06-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"35\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Critical care (Houten, Netherlands)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1186/s13054-022-04050-9\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical care (Houten, Netherlands)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13054-022-04050-9","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients